Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

類似資料

• Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
  著者:: Dieye, Tandakha N., 等
  出版事項: (2013)
• HIV-1 Genetic Diversity and Drug Resistance among Senegalese Patients in the Public Health System
  著者:: Thiam, Moussa, 等
  出版事項: (2013)
• High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat
  著者:: Ekollo Mbange, Aristid, 等
  出版事項: (2021)
• CD4 T-Cell Enumeration in a Field Setting: Evaluation of CyFlow Counter Using the CD4 Easy Count Kit-Dry and Pima CD4 Systems
  著者:: Wade, Djibril, 等
  出版事項: (2013)
• Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression
  著者:: Karam, Farba, 等
  出版事項: (2008)